My understanding is that 25-30% profit with most of the US sales going through the WIC programme is very optimistic - maybe 5% at best?
My educated guess is that A2M management haven’t been asleep at the wheel but made an offer under the FDA exemption to supply a limited number of tins at a minimum margin. They would surely rather direct product to the high margin China market at this point while keeping a door open in the US but under specific terms.
Of course they could all be out playing golf but I think the former is more likely. Come Aug 29th I guess we’ll know more!
Ann: Deferral of FDA consideration of enforcement discretion, page-103
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B | |||
| Open | High | Low | Value | Volume |
| $7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 111 | $7.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.96 | 3799 | 2 |
View Market Depth
| Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |